Form D · Other Health Care
Spark Biomedical Inc.
Dallas, TX · CIK 0001975271
Offering snapshot reported May 12, 2023 · SEC filing
- Reported sold
- $16.2M Offering amount: $21.8M
- Investors reported
- 127 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2023 | Initial | $16,234,159 | No comparison | 127 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481620
Source: Form D, filed May 12, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ted Costopoulos | Director |
| Alejandro Covalin | Director, Executive |
| Carl R. Deeley | Director |
| Navid Khodaparast | Director, Executive |
| Daniel Powell | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
18208 Preston Road, Suite D9 531
Dallas, TX, 75252
Dallas, TX, 75252